Clostridium difficile colitis: a review

Hosp Pract (1995). 2012 Feb;40(1):139-48. doi: 10.3810/hp.2012.02.954.

Abstract

Clostridium difficile has become an increasingly important nosocomial pathogen and is one of the most common causes of hospital-acquired diarrhea. The incidence of C difficile infection (CDI) is increasing worldwide. Overuse of antibiotics is felt to be a major contributing factor leading to the increased incidence of CDI. The clinical manifestations of CDI vary from a mild form of the disease to fulminant diarrhea, leading to significant patient morbidity and mortality. The increasing incidence of CDI has a major impact on increasing health care costs. This article will summarize the epidemiology, pathogenesis, clinical manifestations, laboratory diagnosis, and treatment options for CDI, as well as infection-control measures for the prevention of CDI.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides difficile*
  • Colonoscopy
  • Cross Infection / diagnosis
  • Cross Infection / drug therapy
  • Cross Infection / physiopathology*
  • Diarrhea / diagnosis
  • Diarrhea / microbiology
  • Diarrhea / physiopathology*
  • Enterocolitis, Pseudomembranous / diagnosis
  • Enterocolitis, Pseudomembranous / drug therapy
  • Enterocolitis, Pseudomembranous / physiopathology*
  • Feces / microbiology
  • Humans
  • Immunoenzyme Techniques
  • Infection Control / methods
  • Nucleic Acid Amplification Techniques
  • Probiotics / therapeutic use
  • Risk Factors
  • Severity of Illness Index

Substances

  • Anti-Bacterial Agents